| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| 1 | Conditions listed in this trial | ||||
| Depressive Symptoms | |||||
| Anxiety | |||||
| Cancer | |||||
| 2 | Additional conditions recognized in this trial | ||||
| Depression | |||||
| 3 | More general conditions related to this trial | ||||
| Behavioral Symptoms | |||||
| 4 | Interventions listed in this trial | ||||
| psilocybin | |||||
| 5 | Additional drug interventions recognized in this trial | ||||
| N,N-Dimethyltryptamine | |||||
| Psilocybine | |||||
| 6 | More general drug interventions related to this trial | ||||
| Central Nervous System Agents | |||||
| Hallucinogens | |||||
| Molecular Mechanisms of Pharmacological Action | |||||
| Neurotransmitter Agents | |||||
| Pharmacologic Actions | |||||
| Physiological Effects of Drugs | |||||
| Psychotropic Drugs | |||||
| Serotonin Agents | |||||
| Serotonin Agonists | |||||
| Serotonin Antagonists | |||||
| Therapeutic Uses | |||||
| 7 | Sponsors listed in this trial | ||||
| Sidney Kimmel Comprehensive Cancer Center | |||||
| Heffter Research Institute | |||||
|
